NOTCH1 and B-cell chronic lymphocytic leukemia: used CRISPR/Cas9 technology to edit the WD40 domain in the CLL cell line to cause FBW7 mutations, which could increase the transcription activity and protein level of Notch1 and c-Myc by reducing degradation (18).